Insider · CIK 0001283304

XANTHOPOULOS KLEANTHIS G

Reports to the SEC for 4 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001283304

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-06-10	Zosano Pharma CorpA Award	Director	AAward	+15K sh	—	—	23,596
2021-06-10	Zosano Pharma CorpStock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-06-25	Zosano Pharma CorpA Award	Director	AAward	+7,500 sh	—	—	8,596
2020-06-03	Zosano Pharma CorpStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-01-02	Zosano Pharma CorpStock Option (Right to Buy)A Award	Director	AAward	+1,500 sh	—	—	1,500
2018-05-31	Zosano Pharma CorpStock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-01-04	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2018-01-02	Zosano Pharma CorpStock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2017-01-05	SEELOS THERAPEUTICS, INC.A Award	Director	AAward	+15K sh	—	—	24,575
2016-11-02	Zosano Pharma CorpStock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-09-30	SEELOS THERAPEUTICS, INC.A Award	Director	AAward	+17K sh	$0.34	+$5,750.085	95,746
2016-08-19	Zosano Pharma CorpP Purchase	Director	PPurchase	+15.9K sh	$1.32	+$21K	21,920
2016-08-19	Zosano Pharma CorpSeries A Warrants (right to buy)P Purchase	Director	PPurchase	+15.9K sh	$0.13	+$1,990	15,920
2016-08-19	Zosano Pharma CorpSeries B Warrants (right to buy)P Purchase	Director	PPurchase	+15.9K sh	$0.13	+$1,990	15,920
2016-06-30	SEELOS THERAPEUTICS, INC.A Award	Director	AAward	+14.4K sh	$0.40	+$5,750.004	78,749
2016-04-05	SEELOS THERAPEUTICS, INC.A Award	Director	AAward	+8,621 sh	$0.58	+$5,000.18	64,356
2016-01-04	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2015-04-21	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+60K sh	$0.38	+$22.8K	63,705
2015-04-21	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−60K sh	$17.73	−$1.06M	3,705
2015-04-21	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−60K sh	—	—	8,287
2015-04-20	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+66.1K sh	$0.38	+$25.1K	69,776
2015-04-20	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−66.1K sh	$16.85	−$1.11M	3,705
2015-04-20	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−66.1K sh	—	—	68,287
2015-04-17	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+73.9K sh	$0.38	+$28.1K	77,634
2015-04-17	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−73.9K sh	$16.94	−$1.25M	3,705
2015-04-17	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−73.9K sh	—	—	134,358
2015-04-01	Zosano Pharma CorpA Award	Director	AAward	+6,000 sh	—	—	6,000
2015-03-05	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+89.2K sh	$0.38	+$33.9K	91,696
2015-03-05	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−65.6K sh	$20.06	−$1.32M	26,082
2015-03-05	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−23.6K sh	$20.81	−$492K	2,466
2015-03-05	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−89.2K sh	—	—	208,287
2015-02-27	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+70 sh	$0.38	+$26.6	2,536
2015-02-27	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−70 sh	$19.50	−$1,365	2,466
2015-02-27	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−70 sh	—	—	297,517
2015-02-02	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,400 sh	$0.38	+$912	4,866
2015-02-02	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−2,400 sh	$19.77	−$47.4K	2,466
2015-02-02	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,400 sh	—	—	297,587
2015-01-30	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+3,300 sh	$0.38	+$1,254	5,766
2015-01-30	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−3,300 sh	$19.50	−$64.4K	2,466
2015-01-30	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−3,300 sh	—	—	299,987
2015-01-29	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+60K sh	$0.38	+$22.8K	62,466
2015-01-29	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−33.8K sh	$17.77	−$600K	28,693
2015-01-29	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−26.2K sh	$18.40	−$483K	2,466
2015-01-29	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−60K sh	—	—	303,287
2015-01-28	Regulus Therapeutics Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+85K sh	$0.38	+$32.3K	87,466
2015-01-28	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−72K sh	$17.97	−$1.29M	15,455
2015-01-28	Regulus Therapeutics Inc.S Sale	Director, President and CEO	SSale	−13K sh	$18.69	−$243K	2,466
2015-01-28	Regulus Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−85K sh	—	—	363,287
2015-01-02	SEELOS THERAPEUTICS, INC.Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2014-12-02	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+232K sh	—	—	231,634

Recent filings

Accepted (ET)
Jun 144
XANTHOPOULOS KLEANTHIS G0001567619-21-012084
SEC(opens sec.gov)
Jun 294
XANTHOPOULOS KLEANTHIS G0001140361-20-015096
SEC(opens sec.gov)
Jun 54
XANTHOPOULOS KLEANTHIS G0001567619-20-011809
SEC(opens sec.gov)
Jul 184
XANTHOPOULOS KLEANTHIS G0001567619-19-014978
SEC(opens sec.gov)
Jun 14
XANTHOPOULOS KLEANTHIS G0001587221-18-000031
SEC(opens sec.gov)
Mar 24
XANTHOPOULOS KLEANTHIS G0001587221-18-000002
SEC(opens sec.gov)
Jan 84
XANTHOPOULOS KLEANTHIS G0001017491-18-000015
SEC(opens sec.gov)
Jan 64
APRICUS BIOSCIENCES, INC.0001017491-17-000012
SEC(opens sec.gov)
Nov 44
Zosano Pharma Corp0001209191-16-148482
SEC(opens sec.gov)
Oct 34
APRICUS BIOSCIENCES, INC.0001017491-16-000225
SEC(opens sec.gov)
Aug 224
Zosano Pharma Corp0001587221-16-000005
SEC(opens sec.gov)
Jul 14
APRICUS BIOSCIENCES, INC.0001017491-16-000194
SEC(opens sec.gov)
Apr 74
APRICUS BIOSCIENCES, INC.0001017491-16-000142
SEC(opens sec.gov)
Jan 54
APRICUS BIOSCIENCES, INC.0001017491-16-000097
SEC(opens sec.gov)
Apr 214
Regulus Therapeutics Inc.0001209191-15-035362
SEC(opens sec.gov)

Companies

Address

C/O ANADYS PHARMACEUTICALS, INC. 3115 MERRYFIELD ROW

SAN DIEGO, CA, 92121